Hot Products

Hot products from BioCrick which is a professional high-purity natural products manufacturer are well known to scientists around the world because of their high purity and stability. Each product is a chemical compound or substance produced by a living organism—that is, found in nature. In the broadest sense, natural products include any substance produced by life.Natural products remain the best sources of drugs and drug leads, and this remains true today despite the fact that many pharmaceutical companies have deemphasized natural products research in favor of HTP screening of combinatorial libraries during the past 2 decades. From 1940s to date, 131 (74.8%) out of 175 small molecule anticancer drugs are natural product-based/inspired, with 85 (48.6%) being either natural products or derived therefrom. From 1981 to date, 79 (80%) out of 99 small molecule anticancer drugs are natural product-based/inspired, with 53 (53%) being either natural products or derived therefrom. Among the 20 approved small molecule New Chemical Entities (NCEs) in 2010, a half of them are natural products.

Hot products from the professional high-purity natural products manufacturer

Cat.No. Product Name
BCN7609 8-Deacetylyunaconitine
8-Deacetylyunaconitine is a natural product from Aconitum Vilmorinian Radix.
BCN7610 Meliasendanin D
Meliasendanin D is a natural product from Melia toosendan.
BCN7612 Isohomoarbutin
Isohomoarbutin is a natural product from Pyrola rotundifolia.
BCN7626 Albatrelin A
Albatrelin A is a natural product from Albatrellus ovinus.
BCN7640 3-Acetylyunaconitine
3-Acetylyunaconitine is a natural product from Aconitum episcopale Levl.
BCN7644 Carpalasionin
Carpalasionin is a natural product from Rabdosia lasiocarpa.
BCN7647 Bonducellpin C
Bonducellpin C is a natural product from Caesalpinia minax.
BCN7649 Cudratricusxanthone A
Cudratricusxanthone A has potent anti-proliferative, antioxidative, and monoamine oxidase inhibitory effects, it also possesses anti-cancer activities and provide a basis for developing effective therapeutic agents to inhibit growth and metastasis of breast cancer. Cudratricusxanthone A inhibits lipopolysaccharide-induced neuroinflammation through inhibition of NF-κB and p38 MAPK pathways in BV2 microglia. Cudratricusxanthone A has antiplatelet, anticoagulant, and profibrinolytic activities, it reversibly inhibits CYP1A2, 2C8, and 2C9. It also exhibits the significant hepatoprotective effect on nitrofurantoin-induced cytotoxicity in human liver-derived Hep G2 cells.